Intervention

Placebo tablets

ClinicalTrials.gov intervention label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 16 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials16
Recruiting2
Common conditions16
Lead sponsors shown15
Advertisement

Clinical trials

16 shown
A Study of BGM0504 Tablets in Healthy and Non-diabetic Overweight or Obese Chinese SubjectsNCT07239973 · 2025-10-21
RECRUITING
A Study of Vortioxetine in Japanese Pediatric Patients With Major Depressive DisorderNCT07204314 · 2025-10-01
RECRUITING
A Study to Evaluate the Efficacy and Safety of ENERGI-F705 Tablets for Parkinson's DiseaseNCT07647614 · 2026-12-01
NOT_YET_RECRUITING
The Safety, Tolerability, and Pharmacokinetics Study of HEC113995 PA•H2O Tablets in Healthy SubjectsNCT04591301 · 2019-07-04
COMPLETED
Vortioxetine Intravenous Infusion at Initiation of Oral Treatment With Vortioxetine in Patients With DepressionNCT03766867 · 2018-12-03
COMPLETED
B/F/TAF Ease of Swallowability TrialNCT04600687 · 2018-11-06
COMPLETED
A Single-dose Study to Investigate the Tolerance and Pharmacokinetics of Finamine Tablets in ChinaNCT04162275 · 2017-08-15
COMPLETED
Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a YearNCT02496767 · 2015-09-03
COMPLETED
Safety and Efficacy Study of Losmapimod (GW856553) in Frequently Exacerbating Participants With Chronic Obstructive Pulmonary Disease (COPD)NCT02299375 · 2014-12-09
COMPLETED
Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID.NCT02153645 · 2014-08-18
TERMINATED
Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)NCT01700192 · 2013-01-01
COMPLETED
Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS)NCT01709149 · 2012-10-01
COMPLETED
Immune Reconstitution in HIV Disease (IREHIV)NCT01702974 · 2012-09-01
COMPLETED
A Clinical Study to Evaluate the Safety,Tolerability and PK of ZYT1, Following Oral Administration in Healthy VolunteersNCT01543269 · 2010-02-01
TERMINATED
AZD7268 Safety and Tolerability StudyNCT01020799 · 2009-11-01
COMPLETED
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With SchizophreniaNCT00706654 · 2008-09-01
COMPLETED

Trial status mix

COMPLETED11
RECRUITING2
TERMINATED2
NOT_YET_RECRUITING1

Phase mix

PHASE26
PHASE35
PHASE14
NA1
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.